New Jersey A1154 mandates electronic or written consent from patients or guardians before prescribing certain medications with FDA "black box.
New Jersey A1154 requires physicians, physician assistants, advanced practice nurses, and other authorized prescribers to obtain informed electronic or written consent before prescribing psychotropic medications with FDA "black box warnings." These warnings indicate significant risks of serious or life-threatening adverse effects. If electronic or written consent cannot be obtained, oral consent must be documented in the patient's file. Violation of this requirement subjects the prescriber to disciplinary action by the appropriate State professional licensing board.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.